These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37548149)

  • 1. Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescents.
    Liu M; Zhang J; Li L; Tian J; Yang M; Shang B; Wang X; Li M; Li H; Yue C; Yao S; Lin Y; Guo Y; Zong K; Zhang D; Zhao Y; Cai K; Dong S; Xu S; Zhan J; Gao GF; Liu WJ
    J Med Virol; 2023 Aug; 95(8):e28998. PubMed ID: 37548149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays.
    Seidel A; Hoffmann S; Jahrsdörfer B; Körper S; Ludwig C; Vieweg C; Albers D; von Maltitz P; Müller R; Lotfi R; Wuchter P; Klüter H; Kirchhoff F; Schmidt M; Münch J; Schrezenmeier H
    Front Immunol; 2023; 14():1170759. PubMed ID: 37180152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased antibody titers but induced T cell AICD and apoptosis response in COVID-19 convalescents by inactivated vaccine booster.
    Zhao J; Zhang H; Jiang L; Cheng F; Li W; Wang Z; Liu H; Li S; Jiang Y; Li M; Li Y; Liu S; Fang M; Zhou X; Ye X; Zhao S; Zheng Y; Meng S
    Microbiol Spectr; 2024 Mar; 12(3):e0243523. PubMed ID: 38319108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents.
    Zhang J; Lin H; Ye B; Zhao M; Zhan J; Dong S; Guo Y; Zhao Y; Li M; Liu S; Zhang H; Xiao W; Guo Y; Yue C; Zhang D; Yang M; Zhang J; Quan C; Shi W; Liu X; Liu P; Jiang Y; Wu G; Gao GF; Liu WJ
    Clin Infect Dis; 2022 Aug; 75(1):e1072-e1081. PubMed ID: 34609506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the neutralizing antibodies after the booster dose on SARS-CoV-2 Omicron variant and a two-year longitudinal antibody study on Wild Type convalescents.
    Zheng Y; Pan J; Jin M; Wang J; Tung TH; Chen S; Bi X; Zhou K; Chen M; Wang D; Li J; Shen B; Ying L
    Int Immunopharmacol; 2023 Jun; 119():110151. PubMed ID: 37044040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant neutralizing escapes of Omicron and its sublineages in SARS-CoV-2-infected individuals vaccinated with inactivated vaccines.
    Shen F; Yang CX; Lu Y; Zhang M; Tian RR; Dong XQ; Li AQ; Zheng YT; Pang W
    J Med Virol; 2023 Feb; 95(2):e28516. PubMed ID: 36680413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains.
    Xiao C; Su J; Zhang C; Huang B; Mao L; Ren Z; Bai W; Li H; Lei G; Zheng J; Chen G; Liang X; Qiu C
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines.
    Wang J; Huang L; Guo N; Yao YP; Zhang C; Xu R; Jiao YM; Li YQ; Song YR; Wang FS; Fan X
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection.
    Zhou Y; Chen Z; He Y; Peng X; Chang Y; Tan A; Li H; Cai D; Hu P; Chen M; Peng M; Xu H; Ren H
    Front Cell Infect Microbiol; 2023; 13():1201101. PubMed ID: 37457966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort.
    Tao Y; Ma M; Hu F; Li M; Geng Y; Wan Y; Mao M; Chen L; Shen Y; Zhu L; Shen H; Chen Y
    BMC Immunol; 2022 Nov; 23(1):57. PubMed ID: 36384440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable and durable antibody responses in SARS-recovered donors vaccinated with inactivated SARS-CoV-2 vaccine.
    Jia T; Wu Y; Liao G; Lei Y; Wu Z; Yang F; Chen J; Xie Q; Luo C; Chong Y; Luo H; Shu Y
    J Med Virol; 2023 Mar; 95(3):e28662. PubMed ID: 36905115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination.
    Wang M; Zhou B; Fan Q; Zhou X; Liao X; Lin J; Ma Z; Dong J; Wang H; Ge X; Ju B; Zhang Z
    Emerg Microbes Infect; 2023 Dec; 12(1):2151381. PubMed ID: 36444724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immunity of two-dose inactivated COVID-19 vaccination in Chinese children: A prospective cohort study.
    Wang H; Gan M; Wu B; Zeng R; Wang Z; Xu J; Li J; Zhang Y; Cao J; Chen L; Di D; Peng S; Lei J; Zhao Y; Song X; Yuan T; Zhou T; Liu Q; Yi J; Wang X; Cai H; Lei Y; Wen Y; Li W; Chen Q; Wang Y; Long P; Yuan Y; Wang C; Pan A; Wang Q; Gong R; Fan X; Wu T; Liu L
    J Med Virol; 2023 Jan; 95(1):e28380. PubMed ID: 36478357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization.
    Chen C; Dai L; Zheng C; Li H; Li X; Yang M; Gao R; Yao J; Zhang Z; Shi Y; Han X
    J Hematol Oncol; 2023 May; 16(1):47. PubMed ID: 37138279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].
    Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE
    Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?
    Ravlić S; Kurtović T; Cvetko Krajinović L; Hećimović A; Miloš M; Mateljak Lukačević S; Markotić A; Halassy B
    Hum Vaccin Immunother; 2023 Dec; 19(3):2270310. PubMed ID: 37905722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.
    Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC
    Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in China.
    Yan LN; Zhao ZX; Wang ZD; Xiao X; Liu PP; Zhang WK; Gu XL; Li B; Yu LP; Yu XJ
    Expert Rev Vaccines; 2022 Oct; 21(10):1465-1473. PubMed ID: 35861138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial.
    Taucher C; Lazarus R; Dellago H; Maurer G; Weisova P; Corbic-Ramljak I; Dubischar K; Lilja A; Eder-Lingelbach S; Hochreiter R; Jaramillo JC; Junker H; Krammer M; Pusic P; Querton B; Larcher-Senn J; Hoffmann M; Pöhlmann S; Finn A;
    J Infect; 2023 Sep; 87(3):242-254. PubMed ID: 37406777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.